Waniewski Jacek, Lindholm Bengt
Divisions of Baxter Novum and Renal Medicine, Karolinska Institute, Stockholm, Sweden.
Blood Purif. 2004;22(4):367-76. doi: 10.1159/000080033. Epub 2004 Aug 3.
The efficacy of solute removal by renal replacement therapy can be assessed by the commonly used index of KT/V (the fraction of the volume cleared from a solute). Fractional solute removal (FSR, the fraction of the total amount of the solute that was removed) is an alternative index that may be more appropriate than KT/V for comparison of the efficacy of different treatment modalities. To elucidate the relationship between these two indexes, we propose to discriminate between two notions of clearance: (1) instantaneous clearance K = (solute removal rate)/C(B), where C(B) is solute concentration in blood, and (2) treatment clearance K(T) = (average rate of solute removal per treatment)/C(B), where C(B) is C(B) at the beginning of the treatment. K is the clearance of the purification device (glomeruli, hemodialyzer or hemofilter) and the diffusive mass transport parameter (K(BD), MTAC) for continuous ambulatory peritoneal dialysis (CAPD). For all modalities of renal replacement therapy: FSR = K(T)T/V, and K(T) generally decreases with the treatment time. For purification of a single compartment with a constant volume, V, using an open loop system (i.e. with no recirculation or dwelling of dialysis fluid, as in hemodialysis (HD), hemofiltration (HF) or in the native kidney), FSR is a function of only one lumped, nondimensional parameter, KT/V(B), where V(B) is the distribution volume of the solute within the body. In contrast, if closed loop systems are applied, as for example in HD with recirculation of dialysis fluid (RD) or in peritoneal dialysis, FSR depends on two lumped, nondimensional parameters: KT/V(B) and KT/V(D), where V(D) is the volume of dialysis fluid. It is necessary to discriminate between K and K(T) for analysis of dialysis dose. For HD and HF, FSR is a function of KT/V, whereas KT/V alone does not allow calculation of FSR for CAPD and RD. The current practice of using K(T)T/V for CAPD but KT/V for HD and HF leads to confusion because of the inconsistency in the interpretation of the quantitative prescription of dialysis dose. The application of FSR, instead of KT/V, for all treatment modalities may solve this dilemma. Furthermore, K(T)T/V (currently used only for CAPD) is equal to FSR for all treatment modalities. Both FSR and K(T) may be generalized to describe the total solute removal per treatment cycle composed from a few treatment sessions. A few different definitions of the adequacy parameters for the treatment cycle are formulated and discussed.
肾脏替代疗法溶质清除的疗效可通过常用的KT/V指标(从溶质中清除的体积分数)来评估。分数溶质清除率(FSR,即被清除的溶质总量的分数)是另一种指标,在比较不同治疗方式的疗效时,它可能比KT/V更合适。为了阐明这两个指标之间的关系,我们建议区分两种清除概念:(1)瞬时清除率K =(溶质清除率)/C(B),其中C(B)是血液中的溶质浓度;(2)治疗清除率K(T) =(每次治疗的平均溶质清除率)/C(B),其中C(B)是治疗开始时的C(B)。K是纯化装置(肾小球、血液透析器或血液滤过器)的清除率以及持续非卧床腹膜透析(CAPD)的扩散传质参数(K(BD),MTAC)。对于所有肾脏替代治疗方式:FSR = K(T)T/V,并且K(T)通常随治疗时间而降低。对于使用开环系统(即没有透析液再循环或驻留,如在血液透析(HD)、血液滤过(HF)或天然肾脏中)对体积恒定的单一隔室进行纯化时,FSR仅是一个集中的无量纲参数KT/V(B)的函数,其中V(B)是溶质在体内的分布体积。相比之下,如果应用闭环系统,例如在有透析液再循环(RD)的HD或腹膜透析中,FSR取决于两个集中的无量纲参数:KT/V(B)和KT/V(D),其中V(D)是透析液的体积。在分析透析剂量时,有必要区分K和K(T)。对于HD和HF,FSR是KT/V的函数,而仅KT/V无法计算CAPD和RD的FSR。目前对CAPD使用K(T)T/V而对HD和HF使用KT/V的做法会导致混淆,因为透析剂量定量处方的解释不一致。对所有治疗方式应用FSR而非KT/V可能会解决这一困境。此外,K(T)T/V(目前仅用于CAPD)对于所有治疗方式都等于FSR。FSR和K(T)都可进行推广,以描述由几个治疗时段组成的每个治疗周期的总溶质清除情况。本文提出并讨论了治疗周期充分性参数的几种不同定义。